|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
This is a randomized, double blind, active controlled, parallel group, flexible dose, multicenter study designed to determine the efficacy and safety of paliperidone PR in adolescents 12 to 17 years of age, inclusive, who have a Diagnostic and Statistical Manual of Mental Disorders; 4th Edition (DSM-IV) diagnosis of schizophrenia.
|
|
|
Disease Condition |
Schizophrenia
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Psychiatry
|
|
|
Start date of Trial |
11/19/2009
|
Closing Date of Trial |
11/19/2011
|
|
|
|